BRPI0606583A2 - desenvolvimento e sobrevivência de embrião - Google Patents

desenvolvimento e sobrevivência de embrião

Info

Publication number
BRPI0606583A2
BRPI0606583A2 BRPI0606583-0A BRPI0606583A BRPI0606583A2 BR PI0606583 A2 BRPI0606583 A2 BR PI0606583A2 BR PI0606583 A BRPI0606583 A BR PI0606583A BR PI0606583 A2 BRPI0606583 A2 BR PI0606583A2
Authority
BR
Brazil
Prior art keywords
survival
embryo development
embryo
prostaglandin
development
Prior art date
Application number
BRPI0606583-0A
Other languages
English (en)
Inventor
F Neal Schrick
Original Assignee
Univ Tennessee Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tennessee Res Foundation filed Critical Univ Tennessee Res Foundation
Publication of BRPI0606583A2 publication Critical patent/BRPI0606583A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/02—Compounds of the arachidonic acid pathway, e.g. prostaglandins, leukotrienes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

DESENVOLVIMENTO E SOBREVIVêNCIA DE EMBRIãO. Emlbriào que é transferido no útero de uma fêmea receptora é protegido de efeitos embriotóxicos de prostaglandina F~ 2<244>~ através de exposição de embrião a um antagonista de prostaglandina.
BRPI0606583-0A 2005-01-19 2006-01-13 desenvolvimento e sobrevivência de embrião BRPI0606583A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/039,662 US7705197B2 (en) 2005-01-19 2005-01-19 Embryo development and survival
PCT/US2006/001091 WO2006078535A2 (en) 2005-01-19 2006-01-13 Improving embryo development and survival

Publications (1)

Publication Number Publication Date
BRPI0606583A2 true BRPI0606583A2 (pt) 2009-07-07

Family

ID=36685493

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0606583-0A BRPI0606583A2 (pt) 2005-01-19 2006-01-13 desenvolvimento e sobrevivência de embrião

Country Status (10)

Country Link
US (2) US7705197B2 (pt)
EP (1) EP1845772A4 (pt)
JP (1) JP2008526268A (pt)
CN (1) CN101141876A (pt)
AU (1) AU2006206699B2 (pt)
BR (1) BRPI0606583A2 (pt)
CA (1) CA2594358C (pt)
MX (1) MX2007008696A (pt)
NZ (1) NZ560435A (pt)
WO (1) WO2006078535A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009254181A1 (en) * 2008-06-04 2009-12-10 Proteosys Ag Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances
US10478460B2 (en) 2011-06-14 2019-11-19 J.R. Simplot Company Method for identifying a mammal receptive to embryo transfer
US20160150766A1 (en) * 2013-07-23 2016-06-02 Jennifer BARFIELD Advancing genetic gain in bovine
CN111517551A (zh) * 2020-04-28 2020-08-11 南京优而生物科技发展有限公司 一种辅助生殖技术用液类产品生产用水
CN112603990B (zh) * 2020-12-17 2022-03-08 广州医药研究总院有限公司 提高犬卵巢卵丘-卵母细胞复合体数量的试剂盒及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9227123D0 (en) 1992-12-30 1993-02-24 Applied Research Systems Method
US5955575A (en) * 1997-12-22 1999-09-21 Hopital Sainte-Justine Antagonists of G-protein-coupled receptor

Also Published As

Publication number Publication date
MX2007008696A (es) 2007-10-02
WO2006078535A2 (en) 2006-07-27
CN101141876A (zh) 2008-03-12
AU2006206699B2 (en) 2010-07-08
WO2006078535A3 (en) 2006-12-14
EP1845772A4 (en) 2009-05-27
US8715155B2 (en) 2014-05-06
US20060162003A1 (en) 2006-07-20
JP2008526268A (ja) 2008-07-24
US7705197B2 (en) 2010-04-27
US20080300450A1 (en) 2008-12-04
NZ560435A (en) 2008-12-24
AU2006206699A1 (en) 2006-07-27
CA2594358C (en) 2013-12-31
CA2594358A1 (en) 2006-07-27
EP1845772A2 (en) 2007-10-24

Similar Documents

Publication Publication Date Title
MX2009011938A (es) Composiciones antimicrobianas, productos y metodos de uso.
CR11106A (es) Inhibidores de cinasa p710 s6
CR9331A (es) Inhibidores de vegf-r2 y metodos
MY139896A (en) Improved prrs vaccines
CR10479A (es) Modulares bencimidazolicos de vr1
BRPI0704026A (pt) composições de pós de dispersão que contêm tensoativos duplos
HN2011001810A (es) Sintesis de espirikpiridinas radiomarcadas con 18f a partir de precursores de tosilato y composiciones farmaceuticas estables de estas.
DOP2015000264A (es) Derivados de azaadamantano y métodos de uso de los mismos
HN2008001464A (es) Formulaciones para administrcion parenteral de compuestos y sus usos
CL2011000986A1 (es) Compuestos halosustituidos; uso de dichos compuestos para combatir plagas animales; procedimiento para la preparacion de fitoprotectores; procedimiento para combatir plagas; y compuestos intermediarios.
CL2008003016A1 (es) Composicion para tratamiento de lavanderia que comprende una base de tratamiento de lavanderia y desde 0,01 a 10% en peso de particulas de film laminar concavas coloreadas.
ME01510B (me) MIPO INHIBITORI ZA TRETIRANJE HUNTINGTONOVE BOLESTI l MULTIPLE SISTEMSKE ATROFIJE
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
AR057253A1 (es) Anticuerpos anti-ox40l y metodos que los utilizan
SG163585A1 (en) Melanocortin receptor ligands
AR060695A1 (es) Metodo para dispersar almidon pregelatinizado en agua durante la fabricacion de productos de yeso
CR8879A (es) Bifeniltiazolcarboxamidas
ECSP067110A (es) Derivados de 2-carbamida-4-feniltiazol, su preparación y su aplicación en terapéutica
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
BR112016013194A2 (pt) Composições de higiene oral compreendendo carbonato de cálcio e sílica
CR11765A (es) Derivados de iminopiridina y su uso
UY27852A1 (es) Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
MX394585B (es) Beta-caseina a2 y reducción y prevención de síntomas de intolerancia a la lactosa.
SV2011003827A (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
MX352814B (es) Composiciones para el cuidado oral que comprenden carbonato de calcio y talco.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.